free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

Basic Info

  • Grade: pharmaceutical grade

    Factory Location: Shanghai

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Olatinib is a novel JAK inhibitor that also inhibits the function of JAK1 dependent cytokines in some anti allergic, inflammatory, and itch responses. Research has confirmed that experimental animals (dogs) taking oral doses of 0.4-0.6mg/kg twice a day are safe and effective in treating itching caused by atopic dermatitis, and exhibit better therapeutic effects than oral corticosteroids such as prednisolone. During treatment, olatinib can alleviate itching within 24 hours, and over 70% of experimental animals experienced a reduction of over 50% in itching on the 7th day. Currently, Olatinib has been approved by the US FDA in 2013 to control itching and atopic dermatitis caused by canine allergic dermatitis. However, although Olatinib has a good therapeutic effect on allergic skin diseases in pet dogs, its scope of action is narrow. On the one hand, it has little effect on cytokines that do not participate in activating JAK1. On the other hand, its effect on allergic reactions ultimately only manifests in inhibiting degranulation of mast cells, i.e. the release of allergic mediators. It cannot directly block the binding of allergic mediators to related receptors, nor can it fundamentally block the occurrence and development of allergic skin diseases
Send your message to this supplier
  • From:
  • To:
    Shanghai Hope-chem Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service